LUPRON DEPOT-PED is the only
brand with the flexibility to
individualize CPP treatment with
1-, 3-, and 6-month dosing options3,4

Learn more

LUPRON DEPOT-PED 1-month
is the only GnRHa with 18+ years
of long-term efficacy and
safety data5

Learn more

Support PLUS is your
patient's source for support
throughout treatment

Learn more
GnRHa=Gonadotropin-releasing hormone agonist;
LH=luteinizing hormone.

References: 1. Drugs@FDA: FDA-approved drugs. US Food and Drug Administration. Accessed March 24, 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&AppINo=020263. 2. Data on file, AbbVie Inc. IQVIA NSP, 2023. 3. LUPRON DEPOT-PED [package insert]. North Chicago, IL: AbbVie Inc. 4. National Library of Medicine. DailyMed. Accessed April 17, 2023. https://dailymed.nim.nih.gov/dailymed/search.cfm?adv=1&labeltype=human&query=34067-9%3Acentral+precocious+puberty. 5. Lee PA, Neely EK, Fuqua J, et al. Efficacy of leuprolide acetate 1-month depot for central precocious puberty (CPP): growth outcomes during a prospective, longitudinal study. int J Pediatr Endocrinol. 2011;2011(1):7. doi:10.1186/1687-9856-2011-7.